Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DIMERIX LIMITED Board/Management Information 2015

Dec 16, 2015

64804_rns_2015-12-16_e7f7542e-c8c9-4cea-8f15-256f40aca69a.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

ASX/Media Release

17 December 2015

==> picture [137 x 37] intentionally omitted <==

Dimerix Limited announces appointment of Dr Liz Jazwinska as Non-Executive Director

Melbourne AUSTRALIA, 17 December 2015 : Dimerix Limited (ASX: DXB) is pleased to announce the appointment of Dr Liz Jazwinska as Non-Executive Director.

Dr Jazwinska has more than 25 years experience in R&D Management and drug portfolio business development. She has held senior positions in Industry, Academia and Government bodies in Australia, New Zealand, Singapore and the UK, and is currently the Strategic Alliances Director at the Institute of Medical Biology, A*STAR, Singapore.

Previously, Dr Jazwinska established and led Asia Pacific Partnering Group, at Johnson & Johnson Research Pty Ltd (JJR) in Sydney, responsible for identification and negotiation of Licences and partnerships across Asia. Liz was closely involved in the divestment of the JJR R&D portfolio in 2009 and she led and successfully completed the Series A fund-raising for a new molecular diagnostics company, SpeedX.

Dr Jazwinska holds a BSc (Hons) from Aberdeen University, a PhD from Edinburgh University, an MBA from the Australian Graduate School of Management, and is also a Graduate of the Australian Institute of Company Directors.

Dimerix Limited Executive Chairman Dr James Williams said, “We are very excited to have someone of Liz’s calibre and experience joining the board of Dimerix Limited. Liz’s knowledge of the industry, experience in negotiating research and funding agreements, and substantial network of contacts in biotechnology and pharmaceutical companies and venture capital groups world wide, brings a depth of experience which is complimentary to the existing talent in the team. We look forward to her contribution to all aspects of the Dimerix business.”

For more information please contact:

James Williams Executive Chairman Dimerix Limited Tel: +61 409 050 519

Dimerix Limited (ABN 18 001 285 230) Address: Suite 5, 95 Hay St, Subiaco WA 6008, Australia PO Box 226, Subiaco WA 6904, Australia Web: www.dimerix.com